baber/WOPTO huggingface dataset:
Patent MX-2017004670-A (MX)
Title: Plasticizer composition which comprises cycloalkyl esters of saturated dicarboxylic acids and 1,2-cyclohexanedicarboxylic esters.
Inventor: BORIS BREITSCHEIDEL
IPC: C08K5/10
Filed: 2015-10-08
Abstract: The present invention relates to a plasticizer composition which comprises at least one cycloalkyl ester of saturated dicarboxylic acidsand at least one 1,2- cyclohexanedicarboxylic ester, to molding compositions which comprise a thermoplastic polymer or an elastomer and this plasticizer composition, and to the use of these plasticizer compositions and molding compositions.
Patent MX-2017005282-A (MX)
Title: New compounds as nik inhibitors.
Inventor: MONTANA JOHN GARY
IPC: A61K31/505
Filed: 2015-10-22
Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-Ä¸B-inducing kinase (NIK - also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
Patent MX-2017005457-A (MX)
Title: Gip agonist compounds and methods.
Inventor: LARSEN BJARNE DUE
IPC: C07K14/605
Filed: 2015-10-29
Abstract: The present invention relates to acylated GIP analogues which have GIP agonist activity, and their use in the treatment of metabolic disorders.
Patent MX-2017005795-A (MX)
Title: Modular adapter for tongs.
Inventor: MARTIN HELMS
IPC: E21B19/16
Filed: 2015-10-21
Abstract: A portable tong system includes: a power tong; a backup tong; and an adapter. The adapter includes: a main frame having a base for mounting the backup tong; a mount for mounting the main frame to a positioning system; a leveling frame for torsional connection to the power tong; a suspension mounted to the leveling frame for supporting the power tong; a linear actuator for raising and lowering the leveling frame relative to the main frame; and a torsional arrestor torsionally connecting the leveling frame to the main frame.
Patent MX-2017007136-A (MX)
Title: Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators.
Inventor: Michael MOLLOY
IPC: C07K16/46
Filed: 2015-12-05
Abstract: The receptor for VISTA is identified (VSIG8) as well as the use of this receptor in the identification or synthesis of agonist or antagonist compounds, preferably antibodies, polypeptides and fusion proteins which agonize or antagonize the effects of VSIG8 and/or VISTA and/or the VSIG8/VISTA binding interaction. These antagonists may be used to suppress VISTA's suppressive effects on T cell immunity, and more particularly used in the treatment of cancer, or infectious disease. These agonist compounds may be used to potentiate or enhance VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity, such as in the treatment of autoimmunity, allergy or inflammatory conditions. Screening assays for identifying these agonists and antagonist compounds are also provided.
Patent MX-2017007523-A (MX)
Title: Synergistic herbicidal composition containing penoxsulam, triclopyr and bispyribac.
Inventor: RICHARD K MANN
IPC: A01N43/647
Filed: 2015-11-20
Abstract: A synergistic composition containing penoxsulam, triclopyr, and bispyribac for controlling weeds in crops, especially rice, sugarcane, cereal and grain crops, pastures, rangelands, industrial vegetation management (IVM), aquatics and turf is described herein. These compositions provide improved post-emergence herbicidal weed control and reduce herbicidal injury by concomitant application of the mixture.
Patent MX-2017010734-A (MX)
Title: Combination therapy with coagulation factors and multispecific antibodies.
Inventor: ANDREAS CALATZIS
IPC: C07K16/36
Filed: 2016-04-07
Abstract: The invention relates to therapies for a patient with bleeding disorders, comprising the application of certain blood coagulation (clotting) factors in combination with antibodies.
Patent MX-2017014908-A (MX)
Title: Trispecific binding proteins and methods of use.
Inventor: LUKE EVNIN
IPC: C07K16/28
Filed: 2016-05-20
Abstract: Provided herein are trispecific antigen-binding proteins comprising a domain binding to CD3, a half-life extension domain, and a domain binding to a target antigen. Also provided are pharmaceutical compositions thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such trispecific antigen-binding proteins. Also disclosed are methods of using the disclosed trispecific antigen-binding proteins in the prevention, and/or treatment diseases, conditions and disorders.
Patent MX-2017015182-A (MX)
Title: Method and device for inspection of crankshaft.
Inventor: TOSHIYUKI OYAMA
IPC: G01M99/00
Filed: 2016-05-25
Abstract: [Problem] To provide an inspection method and the like for accurately detecting defects that partially occur in a crankshaft such as underfilling and denting by distinguishing the defects from bending and twisting over the entire length of the crankshaft. [Solution] The present invention includes a step of obtaining three-dimensional point group data over the entire length of a region to be measured of a crankshaft S by an optical three-dimensional shape measurement device 1; a step of dividing the obtained three-dimensional point group data into a plurality of subregions along a direction parallel to the rotational axis L of the crankshaft and generating three-dimensional point group data for each subregion; a step of subjecting the generated three-dimensional group data of each subregion to parallel displacement and rotational displacement to be superimposed on a surface shape model of the crankshaft such that the distance of the three-dimensional point group data of each subregion to the surface shape model of the crankshaft becomes a minimum; and a step of detecting partial defects such as underfilling of the crankshaft on the basis of the distance between the subregional three-dimensional point group data and the surface shape model after the superimposition.
Patent MX-2017016391-A (MX)
Title: Epoxy resin composition.
Inventor: CHRISTIAN BEISELE
IPC: C08G59/68
Filed: 2016-06-03
Abstract: A composition comprising (a) a cationically polymerisable epoxy resin, (b) an thermal initiator for the cationic polymerisation, (c) a microparticle filler, and (d) a nanoparticle filler can be used for the production of thermally stable insulating material for electrical and electronic components.
Patent MX-2018000923-A (MX)
Title: Light system.
Inventor: STUART C SALTER
IPC: F21S10/00
Filed: 2018-01-22
Abstract: A window for a vehicle is provided herein. The window includes a light guide disposed between an outer panel and an inner panel. A light source is optically coupled with the light guide and is configured to direct excitation light towards a luminescent structure. The luminescent structure luminesces in response to receiving the excitation light. A controller is configured to illuminate the light source when an electronic device having an application thereon is in operation.
Patent MX-2018007301-A (MX)
Title: Palatal expansion appliance.
Inventor: SUNG CHUL MOON
IPC: A61C7/10
Filed: 2016-05-09
Abstract: A palatal expansion appliance includes one pair of bone screw joints arranged to face each other, each of the one pair of bone screw joints extending in one direction and having a plurality of bone screw holes formed thereon, and a driving portion arranged between the one pair of bone screw joints, in which, as at least a part of the driving portion is moved in one direction, the one pair of bone screw joints are moved in another direction.
Patent MX-2018009088-A (MX)
Title: Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing the same.
Inventor: LIKUN WANG
IPC: A61P35/00
Filed: 2017-01-23
Abstract: The present invention relates to a trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing same. Specifically, the composition comprises trabectedin and a first excipient, the first excipient being selected from one or more of monosaccharide or polylols . The preparation in the present invention has a stable quality, and can be applied to mass production.
Patent MX-2018009539-A (MX)
Title: Use of microbial communities for human and animal health.
Inventor: SAM POSSEMIERS
IPC: A61P1/00
Filed: 2017-02-03
Abstract: The present invention relates to a mixture of bacteria belonging to at least 6 or 7 different and specific bacterial species preferably for use to prevent or treat gastro-intestinal disorders. Preferably, said mixture of bacteria are grown together in a fermenter prior to administering said mixture to a subject in order to prevent or treat said disorder.
Patent MX-2018009746-A (MX)
Title: Flexible container for concentrated product.
Inventor: MICHELLE CARDONES
IPC: B65D75/58
Filed: 2017-01-25
Abstract: Provided are flexible containers for holding a concentrate, the containers comprising: a flexible body (20) holding the concentrate (40), a spout (30), a filter element (60) disposed in the spout, the filter element comprising a filter (80) and an attachment element (68) configured to attach to a water source. Also provided are methods of reconstituting concentrated products using the flexible containers.
Patent MX-2018013941-A (MX)
Title: Combination therapy with notch and pd-1 or pd-l1 inhibitors.
Inventor: BHARVIN KUMAR PATEL
IPC: A61K45/06
Filed: 2017-05-16
Abstract: The present invention provides medicaments for use in treating and methods of treating T- cell acute lymphoblastic leukemia, acute lymphoblastic leukemia, chronic lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, erythroleukemia, triple negative breast cancer, breast cancer, ovarian cancer, melanoma, Sung cancer, non small-cell lung cancer, pancreatic cancer, glioblastoma, colorectal cancer, head and neck cancer, cervical cancer, prostate cancer, liver cancer, oral squamous cell carcinoma, skin cancer, medul!ob!astoma, hepatocellular carcinoma, intrahepatic and extrahepatic cholangiocarcinoma, desmoid tumor, soft tissue sarcoma, or adenoid cystic carcinoma in a patient comprising combination therapy with 4,4,4-trifluoro-N-[(1S)-2~[[(7S)-5-(2-hydroxyemyl)-6-oxo-7H-pyr ido[23-d][3]benzazepin-7-yl]amino]-1-methyl-2-oxo- ethyljbutanamide, or a pharmaceutically acceptable salt or hydrate thereof, and a PD-1 or a PD-L1 inhibitor selected from pembrolizumab, nivolumab, atezolizumab, durvalumab, and avelumab.
Patent MX-2019002043-A (MX)
Title: Inter-band handover of the same physical frequency.
Inventor: PETER ALRIKSSON
IPC: H04L5/00
Filed: 2016-09-01
Abstract: A method of an access network node of a carrier aggregation enabled cellular wireless communication system, and a method of a wireless terminal device of a carrier aggregation enabled cellular wireless communication system are disclosed. The method for the network node comprises identifying a need for an inter-band handover where a same physical frequency on which the access network node interacts with a wireless terminal device has more than one logical reference, wherein the wireless terminal device currently operates using a first logical reference, assigning a target frequency for the inter-band handover as a second logical reference for the physical frequency, and performing handover signalling with the wireless terminal device including the assigned target frequency. The method of the wireless terminal device comprises performing operation where a need for an inter-band handover occurs where a same physical frequency on which the wireless terminal device interacts with an access network node of the cellular wireless communication system has more than one logical reference, wherein the wireless terminal device currently operates using a first logical reference, and performing handover signalling with the access network node including receiving an assigned target frequency which is a second logical reference for the physical frequency. A network node, a wireless terminal device and computer programs for these for implementing the methods are also disclosed.
Patent MX-2019002575-A (MX)
Title: Biodegradable microcapsules containing filling material.
Inventor: CHRISTOPHER A RHODES
IPC: A61K31/704
Filed: 2015-03-20
Abstract: Biodegradable microcapsules include a biodegradable polymer shell and filling material. The polymer shell completely encompasses the filling material. The filling material may include one or more biodegradable microparticles or a therapeutic agent or both.
Patent MX-2019004422-A (MX)
Title: Apparatus and methods for launching guided waves via an antenna.
Inventor: IRWIN GERSZBERG
IPC: H01P5/02
Filed: 2017-09-14
Abstract: Aspects of the subject disclosure may include, for example, a system having an antenna for launching, according to a signal, a first electromagnetic wave to induce a propagation of a second electromagnetic wave along a transmission medium, the second electromagnetic wave having a non-fundamental wave mode and a non-optical operating frequency. A reflective plate is spaced a distance behind the antenna relative to a direction of the propagation of the second electromagnetic wave. Other embodiments are disclosed.
Patent MX-2019006657-A (MX)
Title: Fast switching back-up power supply system employing rechargeable electrochemical cells.
Inventor: RAMKUMAR KRISHNAN
IPC: H02J9/06
Filed: 2018-04-09
Abstract: A back-up rechargeable battery supply system (10) comprises communication linkages and a configuration of switches (75, 85, 90, 92) to allow battery back-up power to be provided by cells (80) within a battery unit that are in a ready mode and to by-pass batteries that are in a non-ready mode, or maintenance mode. The unique configuration of switches (75, 85, 90, 92) and communication methods enables the back-up power to be provided very quickly to avoid disruptions in power to a load (12). Each battery cell (80) has a charge (92) and discharge switch (90) and a power switch (75). Both the power switch (75) and one of the charge (92) or discharge switches (90) must be closed to allow the battery cell to charge or discharge respectively. The by-pass switch (85) may be controlled by the battery system control (70) or by the cell controller (87) and when closed, the cell (80) may be bypassed from discharging or charging. The battery cells (80) may be electrochemical cells such as metal air batteries.
Patent MX-2019006972-A (MX)
Title: Balloon catheters and methods thereof.
Inventor: KAREN A DICLAUDIO
IPC: A61B17/3207
Filed: 2017-12-12
Abstract: Provided herein in some embodiments is a catheter including an elongate body with a polymeric portion and a metallic portion; a balloon over at least some of the polymeric portion; a coupler formed over or between the polymeric and metallic portions; and one or more scoring wires. The metallic portion can include a spiral-cut portion configured to prevent elongation and kinking of the elongate body. The one or more scoring wires can be fixed to and extend from a tip at a distal end of the elongate body, over the balloon, through the polymeric portion of the elongate body, through the coupler, and to the metallic portion of the elongate body. The one or more scoring wires can be fixed to an internal surface of the spiral-cut portion or formed from the spiral-cut portion.
Patent MX-2019007684-A (MX)
Title: Novel compound and pharmaceutically-acceptable salt thereof.
Inventor: KEIJI TAMURA
IPC: A61K31/541
Filed: 2017-12-26
Abstract: Provided is a compound represented by general formula (1) or a pharmaceutically-acceptable salt thereof. [In formula (1), R1 and R2 may be the same or different from each other, and each represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxy group, a cyano group, or an optionally-substituted C1-6 alkyl group or the like; R3 represents a hydrogen atom; R4 represents an optionally-substituted 4- to 10-membered monocyclic heterocyclic group containing 1-4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by -CH2-, -CH2-CH2-, -CH2-CH2-CH2-, or -CH2-O-CH2-; and Z represents a hydrogen atom or a hydroxy group.].
Patent MX-2019009870-A (MX)
Title: Use of copolymers as binders for pelletizing metal containing ores.
Inventor: BJÖRN LANGLOTZ
IPC: C22B1/243
Filed: 2018-02-22
Abstract: The present invention relates to the use of copolymers as binders for pelletizing metal containing ores such as iron containing ores. The copolymers comprise monomer units derived from at least one monomer C of formula (I).
Patent MX-2019015273-A (MX)
Title: Modulators of alpha-synuclein.
Inventor: LEE JAE MOON
IPC: A61K31/415
Filed: 2018-06-19
Abstract: The disclosure provides diagnostic methods and methods for treatment of conditions arising from alpha-synucleopathies. An aminopyrazole compound can be used for treatment of such conditions by lowering the amount of alpha-synuclein in cells of a subject.
Patent MX-2020002381-A (MX)
Title: Prostamide-containing intraocular implants and methods of use thereof.
Inventor: ROBINSON MICHAEL R
IPC: A61K31/5575
Filed: 2016-04-27
Abstract: Prostamide-containing intraocular implants that biodegrade in the eye and that are effective for reducing intraocular pressure in an eye for a sustained period. The implants generally contain a prostamide, such as bimatoprost, and at least three distinct biodegradable polymers selected from polylactide and poly(lactide-co-glycolide) polymers and are optimized for placement in and compatibility with the anterior chamber of the eye, particularly the anterior chamber angle. Methods for making and using the implants to reduce ocular hypertension and intraocular pressure in a patient are described.
Patent MX-2020002463-A (MX)
Title: System for loading leg meat on the bone.
Inventor: CHIMURA TAKESHI
IPC: A22C21/00
Filed: 2018-10-05
Abstract: A system (10) for loading leg meat on the bone according to one embodiment of the present invention is for loading leg meat on the bone into processing units (12), and is provided with: an imaging unit (14) for imaging the leg meat on the bone before loading into the processing units; an image processing unit (16) which is capable of acquiring orientation information related to thigh meat on the bone from images of the leg meat on the bone imaged by the imaging unit; a pair of clamp pieces which are capable of opening and closing in order to grip the leg meat on the bone; arms (20) which support the pair of clamp pieces, and which are capable of controlling the position and orientation of the pair of clamp pieces; and a control unit which controls the operation of the arms on the basis of the orientation information acquired by the image processing unit, to grip the leg meat on the bone and load the leg meat on the bone into the processing units.
Patent MX-2020003601-A (MX)
Inventor: NEUNTEUFEL MARTIN
IPC: D04B21/00
Filed: 2018-09-20
Abstract: La invención se refiere a un tejido de punto. Existe la necesidad de tejidos de punto hechos que sean confortables de usar, tengan buena lavabilidad y alta suavidad. La buena lavabilidad implica tanto estabilidad dimensional del tejido como mantener aspectos de superficie positivos tales como calidad de peludo, pilling y empalme de fibra incluso después de varios lavados. Este objetivo se resuelve de acuerdo con la invención mediante un tejido de punto hecho a partir de al menos un hilo el cual consiste en o contiene filamentos de lyocell. El tejido resultante tiene un alto confort de uso y cualidades mecánicas superiores.
Patent MX-2020005660-A (MX)
Title: Use of kor agonist in combination with mor agonist in preparing drug for treating pain.
Inventor: CAO GUOQING
IPC: C07D405/02
Filed: 2018-12-05
Abstract: Disclosed is the use of a KOR agonist in combination with a MOR agonist in preparing a drug for treating pain. The KOR agonist is selected from a compound as shown in the general formula (I), and the MOR agonist is selected from a compound as shown in the general formula (II), wherein the definitions of each substituent in the general formula (I) and (II) are the same as defined in the description.
Patent MX-2020013909-A (MX)
Title: Stopper device, medicament container, and method for mixing two substances in a medicament container.
Inventor: MESSNER-RUGOVA FATBARDHA
IPC: A61J1/20
Filed: 2019-06-28
Abstract: The invention relates to a stopper device (1) for sealing off a medicament container (45) with a stopper element (3), wherein the stopper device is designed to seal off the medicament container (45) in an axial direction of a centre axis (M) of the medicament container (45), wherein the stopper device (1) is at least partially insertable into the medicament container (45), and the stopper element (3), in the intended installation position in the medicament container (45), is displaceable along the centre axis (M) of the medicament container (45). Provision is made that the stopper device (1) has a retention region (23) with at least one retention means (5), wherein a closure element (7), in a first functional state of the stopper device (1), is retained by the retention means (5) in a fixed position relative to the stopper element (3), in particular retained releasably in a retention position on the stopper element (3), in such a way that a cavity (29) is formed between the closure element (7) and the stopper element (3).
Patent MX-2021000714-A (MX)
Title: Medicinal preparation for external use.
Inventor: TANAKA MASAYASU
IPC: A61P29/02
Filed: 2019-07-18
Abstract: The present invention pertains to a drug for the treatment and/or prevention of pain, more specifically to a medicinal preparation for external use to treat and/or prevent peripheral neuropathic pain, the medicinal preparation containing as an active ingredient N<sup>2</sup>-{[1-ethyl-6-(4-methylphenoxy)-1H-benzimidazol-2-y l]methyl}-L-alaninamide.
Patent MX-2021002512-A (MX)
Title: Alkyl enol ether properfume.
Inventor: INDRADAS BRINDA
IPC: C07C45/36
Filed: 2019-12-19
Abstract: The present invention relates to compounds of formula (I) as properfume compounds. In particular, the present invention relates to a method to release a compound being a ketone of formula (II), a formate ester of formula (III) and/or an alcohol of formula (IV) by exposing the compound of formula (I) to an environment wherein it is oxidized. Moreover, the present invention relates to a perfuming composition and a perfumed consumer product comprising at least one compound of formula (I).
Patent MX-2021002561-A (MX)
Title: Recombinant expression of fumonisin amine oxidase.
Inventor: GARNHAM CHRISTOPHER PETER
IPC: C12N1/15
Filed: 2019-09-04
Abstract: Fumonisins are a type of mycotoxin that contaminate different products, for example, feed and food products, including corn-based products, which can lead to serious health risks to humans and livestock. Current methods for detoxifying fumonisin-contaminated products are complex and expensive. The present disclosure provides a recombinant microbial host cell expressing an heterologous polypeptide having fumonisin amine oxidase activity, the recombinant microbial host cell comprising an heterologous nucleic acid molecule encoding the heterologous polypeptide having fumonisin amine oxidase activity, a variant thereof or a fragment thereof. The heterologous polypeptide having fumonisin amine oxidase activity can be used to detoxify a fumonisin mycotoxin present in feed and food products, for example from grains and products derived from grains.